(PDF) Implementation of Basal–Bolus Therapy in Type 2

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch With an Insulin Pen

Diabetes Technology and Therapeutics - United States

doi 10.1089/dia.2018.0298

Full Text

Open PDF

Abstract

Available in full text

Date

May 1, 2019

Authors

Richard M. Bergenstal

Publisher

Mary Ann Liebert Inc

Amanote Research

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch With an Insulin Pen

Diabetes Technology and Therapeutics - United States

doi 10.1089/dia.2018.0298

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes

Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial

Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery With Type 1 Diabetes

Premixed vs Basal-Bolus Insulin Regimen in Type 2 Diabetes: Comparison of Clinical Outcomes From Randomized Controlled Trials and Real-World Data

The Relationships Between Glucose Variability and Renal Function in Type 2 Diabetes Patients on Basal-Bolus Insulin Therapy

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Management and Healthcare Resource Use When Intensifying From Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Basal-Bolus Insulin Therapy in Postoperative Inpatients With Diabetes Mellitus: Directions for Future Quality-Improvement Initiatives

Peri-Operative Management of Patients With Type-2 Diabetes Mellitus Undergoing Non-Cardiac Surgery Using Liraglutide, Glucose-Insulin-Potassium Infusion or Intravenous Insulin Bolus Regimens: A Randomised Controlled Trial